In order to further standardize and guide immunogenicity studies of drugs and provide technical references for the industry, researchers and regulatory authorities, the CDE, under the guidance of NMPA, has organized to formulate the Technical Guidance for Immunogenicity Studies of Drugs, which was issued and implemented as of March 5.